GSK GSK plc

NYSE
$49.52

GSK plc (GSK) is expected to report earnings on October 27, 2026, before the market open. The consensus earnings estimate is $1.46 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.7% since its last earnings release on July 28, 2026.

GSK plc Beat Consensus Estimates
Tuesday, July 28, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 27
Tuesday · Before Open
Earnings Whisper
-
vs $1.46
Rev est $11.59B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $51.92

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About GSK plc

GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 1 ETFs, by dollar flow